Drug Topics
OCTOBER 2, 2024
In an installment of Drug Topics’ 5 Questions With a Pharmacist, Lea Wolsoncroft of Remedies Pharmacy in Hoover, Alabama, discussed what is going on in her pharmacy practice.
PharmaVoice
OCTOBER 4, 2024
Cassava Sciences’ beleaguered investigational Alzheimer’s therapy is in two phase 3 studies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
OCTOBER 2, 2024
Lowering prescription drug costs for patients, saving taxpayers money, helping small businesses level an anti-competitive playing field: all of this is at stake.
STAT
OCTOBER 4, 2024
Experimental vaccines and therapeutics to combat the deadly Marburg virus will begin arriving this weekend in Rwanda, where they will be used in clinical trials expected to begin soon, a U.S. government official confirmed on Friday. There are currently no licensed vaccines or drugs to prevent or treat Marburg, a cousin of the Ebola family of viruses that transmits and causes illness in the same way as Ebola.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 3, 2024
Senators Ron Wyden and Sherrod Brown wrote a letter to the Federal Trade Commission calling to explore yet another PBM tactic impeding competition.
PharmaVoice
OCTOBER 1, 2024
Mark your calendars for the most important industry conferences in 2025.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 2, 2024
U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird flu passed the virus on to others, causing a delay that will likely fuel concerns about the possibility that there has been human-to-human transmission. The Centers for Disease Control and Prevention has blood samples from several health workers and a household contact of the Missouri case that it plans to test for antibodies that would indicate whether they too had been
Drug Topics
OCTOBER 4, 2024
Check out important updates from the FDA for the week of September 30.
PharmaVoice
OCTOBER 3, 2024
As respiratory disease season approaches, experts are concerned about vaccination rates — but the industry is churning out new solutions to help.
Pharmacy Times
OCTOBER 1, 2024
The accelerated course was safe and effective and did not increase complications in patients with breast cancer post-mastectomy undergoing breast reconstruction.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 2, 2024
For nearly a year, my stance on Cassava Sciences and its Alzheimer’s disease drug candidate simufilam has been clear: Emerging evidence shows the drug is inert, and patients with Alzheimer’s were misled into participating in ongoing Phase 3 clinical trials, so therefore, the Food and Drug Administration must take immediate steps to protect these vulnerable people from further harm.
Drug Topics
OCTOBER 4, 2024
Social pressures, physiological changes, mental health challenges, and burnout all complicate diabetes management among adolescents.
Fierce Healthcare
OCTOBER 1, 2024
Two key senators are urging the Federal Trade Commission to investigate "co-manufacturing" arrangements that they fear pharmacy benefit managers may be using to stymie competition. | Two key senators are urging the Federal Trade Commission to investigate "co-manufacturing" arrangements that they fear pharmacy benefit managers may be using to stymie competition.
Pharmacy Times
OCTOBER 4, 2024
The new screening test provides an easier, convenient option for patients seeking to screen themselves for colorectal cancer.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
OCTOBER 1, 2024
A year ago last week, Jeanne Marrazzo stepped into a very big pair of shoes. Marrazzo became the first new director of the National Institute of Allergy and Infectious Diseases in decades, taking over a job held for 38 years by Anthony Fauci, whose long-term status as a science god in Washington gave way to Covid-19 fall guy in some quarters during and after the pandemic.
Drug Topics
OCTOBER 1, 2024
Researchers compared the cardiovascular outcomes of patients hospitalized for heart failure that did or did not experience diabetic emergencies.
Fierce Healthcare
OCTOBER 1, 2024
A new analysis points to troubling trends in the U.S. healthcare market as costs continue to rise but health outcomes are declining. | "The inputs of the U.S. healthcare system, as measured by cost, exceed the outputs, as measured by the actual value or benefits received by Americans," Sanjula Jain, Ph.D., Trilliant Health's chief research officer, said.
Pharmacy Times
OCTOBER 3, 2024
Fedratinib is an orally available, small molecule inhibitor of JAK-2 approved for treatment of myelofibrosis.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
OCTOBER 1, 2024
Often, women with sickle cell disease are told not to have kids. They might come to an appointment, happily pregnant, only for the doctor to tell them they shouldn’t be. They might be preparing for a scheduled C-section when their OB-GYN says that this pregnancy has gone smoothly but the next one could kill them. The illness is associated with an increased risk of serious pregnancy complications, which warrants a discussion — but sometimes that discussion can blur the line between
Drug Topics
SEPTEMBER 30, 2024
Researchers addressed the association between older individuals who received an influenza vaccine and their risk of stroke following vaccination.
Fierce Healthcare
OCTOBER 1, 2024
Hospital programs providing at-home acute care are widely appreciated by patients and clinicians but still don’t have a bulletproof argument in respect to quality and costs as compared to a brick-a | A new 79-page government report on the soon-to-expire Acute Hospital Care at Home initiative outlines both clear-cut and muted wins for advocates.
Pharmacy Times
SEPTEMBER 30, 2024
MDL-101 is a proposed novel precision medicine that targets the LAMA1 gene, causing LAMA2 congenital muscular dystrophy type 1a.
STAT
SEPTEMBER 30, 2024
A large outbreak of Marburg virus in Rwanda is drawing international concern about the possibility of spread beyond the country’s borders. The number of cases detected so far, 27 , already makes the outbreak one of the biggest involving Marburg on record. Nine of those individuals have died. There are currently no licensed vaccines to combat the disease.
Drug Topics
SEPTEMBER 28, 2024
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
IDStewardship
OCTOBER 3, 2024
Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 30 September 2024 I recently had the honor to give a key note speech for my alma matter, Northeastern University in Boston, MA. It took me a while to put the thoughts together and I had some support from my friend Dr. Robert Kraljevich. It seems like other people might potentially benefit from reading this and learning from my 20 years of experience in the pharmacy biz… so I put it on this webpage!
Pharmacy Times
SEPTEMBER 28, 2024
Experts discuss emerging targets in the immunotherapy landscape and how to improve patient outcomes through innovative approaches.
STAT
SEPTEMBER 30, 2024
Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs even lost their bonuses. But the biggest names in health care still made $3.5 billion combined last year, compared with $4 billion in 2022. The average chief executive brought home $11 million, while the median was $4.1 million.
Drug Topics
SEPTEMBER 28, 2024
Check out this recap of articles published on our sister sites during the past week.
PharmaVoice
OCTOBER 2, 2024
The official launch comes five months after a filing indicated major investors such as Atlas Venture and Bain Capital were backing the biotech, then named “Hercules CM NewCo.
Pharmacy Times
SEPTEMBER 28, 2024
Small molecule agents continue to be beneficial additions to multiple myeloma treatment, even with the development of T-cell redirected therapies.
STAT
OCTOBER 1, 2024
Across all kinds of cancer, Black Americans have higher rates of mortality and, often, more aggressive forms of the disease. A growing body of research suggests the reasons may not have to do with African ancestry as much as social and environmental factors like racism, housing discrimination , and — according to a new study — exposure to pollution.
Drug Topics
SEPTEMBER 30, 2024
Sara T. Thomason discuses the impact of stigma on pharmacists who are dealing with substance use disorder, the importance of mental health care, and how schools support pharmacy students dealing with addiction.
PharmaVoice
OCTOBER 2, 2024
Biosimilar competition will erode billions from the pharma giant’s bottom line in the next few years.
Expert insights. Personalized for you.
503 
Let's personalize your content